Baxter has notably underperformed the Medical Devices industry over the past year, and analysts are cautious about the ...
Transition amid governance reviews and safety investigations continues Interim finance chief brings background and public ...
Baxter International (BAX) is back in focus after a cluster of analyst downgrades and fresh legal investigations into alleged fiduciary breaches, supply chain disclosures, and Novum LVP product safety ...
In recent days, Baxter International has faced renewed legal scrutiny as law firms announced investigations into alleged ...
Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.
Joel Grade to depart as Baxter CFO; Anita Zielinski named interim CFODEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International ...
Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.
Baxter announced today that EVP and CFO Joel Grade is departing the company and a search is underway for a replacement.
Baxter International stock has reached a new 52-week low, touching $16.99, bringing the healthcare equipment company’s market capitalization to $8.76 billion. Despite the decline, InvestingPro ...
StockStory.org on MSN
1 unprofitable stock with impressive fundamentals and 2 that underwhelm
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a ...
ProShares S&P 500 Ex-Technology ETF is a passively managed ETF offering exposure to the S&P 500 without the GICS IT sector.
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results